Sourav Kundu - 15 Jul 2021 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
Sr VP, Dev. & Mfg.
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for Sourav K. Kundu
Issuer symbol
NXTC
Transactions as of
15 Jul 2021
Net transactions value
$0
Form type
4
Filing time
19 Jul 2021, 16:07:10 UTC
Previous filing
15 Jul 2021
Next filing
02 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXTC Employee Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 15 Jul 2021 Common Stock 150,000 $7.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth of the option vests on July 6, 2022. The remainder vests in 36 monthly installments beginning on August 6, 2022.